Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer

Clinical trial NCT03018249 · COMPLETED

Trial details

NCT number: NCT03018249
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma FIGO Grade 3 Endometrial Endometrioid Adenocarcinoma

Start date: 2017-10-11
Primary completion: 2018-04-18
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.